Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Nfocus Neuromedical Announces FDA 510(k) Clearance for Next Generation Device to Treat Vascular Lesions

January 11, 2011 By Bio-Medicine.Org

PALO ALTO, Calif., Jan. 11, 2011 /PRNewswire/ — Nfocus
Neuromedical, Inc., an innovative medical device company with a
focus on the next generation treatment for brain aneurysms, today
announced that the company received U.S. Food and Drug
Administration 510(k) clearance for its Acta™ Vessel
Occlusion System (VOS).  The Acta VOS provides physicians with
a minimally-invasive alternative to current treatment options for
an array of common and potentially serious vascular lesions.

The Acta VOS is designed to occlude (close) targeted veins and
arteries with great precision. Vascular occlusion is often used to
block blood flow to malformed, weakened or leaking vessels, or to
benign or malignant tumors.

“The Acta VOS and the Nfocus technology platform on which it’s
based address an important and, to this date, insufficiently
resolved medical need,” said Eric Milledge, chairman and CEO,
Nfocus Neuromedical.  “The Acta 510(k) clearance is a tangible
demonstration of our company’s progress and is the first step
toward clearance of the Nfocus platform of braided occluders, which
includes the Luna™, our flagship product for treating brain
aneurysms.”

Vascular occlusions were historically accomplished by surgically
closing the targeted blood vessel – a traumatic and expensive
procedure. More recently, surgeons began placing small wire coils
and other vascular plugs through catheters to stop blood from
flowing to the area of concern. However, several coils may be
required to occlude a single vessel, and occlusions frequently
re-open. Pre-clinical studies demonstrate that the Acta VOS stops
blood flow in a vessel more quickly and durably than both coils and
a predicate plug device.

The Acta VOS uses a self-expandable, multi-layer oval implant
made from Nitinol, a nickel-titanium alloy. Nitinol’s properties
allow the device to easily compress within a conventional catheter,
and then rapidly open to full size once deployed

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech